127 related articles for article (PubMed ID: 3519061)
1. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
De Martiis M; Parenzi A; Barlattani A; De Martiis A
Clin Ter; 1986 Mar; 116(5):367-71. PubMed ID: 3519061
[No Abstract] [Full Text] [Related]
2. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
Diener HC
MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
[No Abstract] [Full Text] [Related]
3. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
Guiraud-Chaumeil B; Rascol A; David J; Boneu B; Clanet M; Bierme R
Rev Neurol (Paris); 1982; 138(5):367-85. PubMed ID: 6815756
[No Abstract] [Full Text] [Related]
4. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
[No Abstract] [Full Text] [Related]
5. [Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke].
Schwab S
MMW Fortschr Med; 2009 Jul; 151(30-33):60-1. PubMed ID: 19722467
[No Abstract] [Full Text] [Related]
6. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Bousser MG
J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
[TBL] [Abstract][Full Text] [Related]
8. Use of dipyridamole in patients with recent stroke or TIA.
Bernstein RA
Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
[No Abstract] [Full Text] [Related]
9. [Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
De Schryver EL; Gorter JW; Algra A; van Gijn J
Rev Med Interne; 1999 May; 20(5):397-9. PubMed ID: 10365408
[No Abstract] [Full Text] [Related]
10. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
11. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
Schrama E; Eusman JP
Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2672; author reply 2672-3. PubMed ID: 17205946
[No Abstract] [Full Text] [Related]
12. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
[No Abstract] [Full Text] [Related]
13. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
Offerhaus L
Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2673; author reply 2673-4. PubMed ID: 17205947
[No Abstract] [Full Text] [Related]
14. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
15. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
16. [After stroke or TIA. Double protection by second platelet inhibitor].
MMW Fortschr Med; 2003 Dec; 145(50):57. PubMed ID: 14963978
[No Abstract] [Full Text] [Related]
17. [Prevention of recurrence of cerebrovascular thromboses. A randomized comparative study of acetylsalicylic acid and sodium pentosan polysulfate].
Vinazzer H
Fortschr Med; 1987 Feb; 105(5):79-85. PubMed ID: 2435643
[No Abstract] [Full Text] [Related]
18. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
Thijs V; Lemmens R; Fieuws S
Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
[TBL] [Abstract][Full Text] [Related]
19. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
20. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
Apollonio A; Castignani P; Magrini L; Angeletti R
J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
